Почетна › Кронова болест › Оклахома
Kliničke studije za Кронова болест u državi Оклахома
7 studija za Кронова болест traži učesnike na lokacijama u državi Оклахома.
Gradovi u državi Оклахома
Zvanični tekst studije (na engleskom)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Disease Specialists Inc, Oklahoma City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577843A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Disease Specialists Inc, Oklahoma City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Central Sooner Research-Site Number: 8400094, Norman
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- The University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06405087Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- The University of Oklahoma Health Sciences Center, Oklahoma City
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 8. 2026. · NCT06100289Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.